Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CCR5 and CD4 siRNA-targeted phospholipid nanosomes therapeutics for treatment of HIV-1 and other diseases

CCR5 and CD4 siRNA-targeted phospholipid nanosomes therapeutics for treatment of HIV-1 and other diseases

US Patent 11981714 · Granted May 14, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Room temperature stable, single shot mRNA vaccine for COVID-192025
Adeno-associated virus compositions for restoring HBB gene function and methods 2025
Adeno-associated virus compositions for restoring PAH gene function and methods 2025
Thermal conversion of CBDA and other carboxylic cannabinoids2024
Adeno-associated virus compositions for restoring F8 gene function and methods o2024
Compositions and methods for modulating MECP2 expression2023
Bryoid compositions, methods of making and use thereof2023
Adeno-associated virus compositions for restoring F8 gene function and methods o2022
Combination HIV therapeutic2022
Bryoid compositions, methods of making and use thereof2021
RNA interference mediated inhibition of gene expression using chemically modifie2021
Compositions and methods for modulating SMN gene family expression2020